It has been shown resveratrol can stimulate
the creation of adiponectin hormone which promotes metabolic health through improved lipid (fat) metabolism, regulation of blood glucose levels and weight loss.
Since
adiponectin binds to two receptors, AdipoR1 and AdipoR2, Yokoyama, who leads the RIKEN Structural Biology Laboratory, and his team surmised that understanding how this binding takes place could contribute to the
creation of drugs that target these receptors.